AR010337A1 - Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacuna - Google Patents
Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacunaInfo
- Publication number
- AR010337A1 AR010337A1 ARP970105740A ARP970105740A AR010337A1 AR 010337 A1 AR010337 A1 AR 010337A1 AR P970105740 A ARP970105740 A AR P970105740A AR P970105740 A ARP970105740 A AR P970105740A AR 010337 A1 AR010337 A1 AR 010337A1
- Authority
- AR
- Argentina
- Prior art keywords
- nucleic acid
- pylori
- polypeptide
- producing
- vaccine
- Prior art date
Links
- 102000039446 nucleic acids Human genes 0.000 title abstract 7
- 108020004707 nucleic acids Proteins 0.000 title abstract 7
- 150000007523 nucleic acids Chemical class 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 5
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 241000589989 Helicobacter Species 0.000 title abstract 2
- 239000013604 expression vector Substances 0.000 title abstract 2
- 238000003259 recombinant expression Methods 0.000 title abstract 2
- 239000000523 sample Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 abstract 2
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 108020001507 fusion proteins Proteins 0.000 abstract 1
- 102000037865 fusion proteins Human genes 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K2039/106—Vibrio; Campylobacter; Not used, see subgroups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Un ácido nucleico aislado que comprende una secuencia nucleotídica que codifica un polipéptido de H.pylori que es por lo menos aproximadamente 60%homologa con una secuencia de animoácido seleccionada del grupo que consiste en SEC ID N* 98-SECID N* 194; ácido nucleico aislado, molécula de ácido nucleico,sonda, vector de expresion recombinante, célula, método para producir un polipéptido de H. Pylori, método para detectar la presencia de un ácidonucleico helicobacter, polipéptidode H . pylori aislado, proteína de fusion, formulacion para vacuna para tratamiento profiláctico o terapéutico de unainfeccion de H.pylori, método para tratar o reducir un riesgo de contraer la infeccion de H,pylori, método para producir unaformula cion para vacuna ypolipéptido de H.pylori quimérico.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75962596A | 1996-12-05 | 1996-12-05 | |
| US82374597A | 1997-03-25 | 1997-03-25 | |
| US89192897A | 1997-07-14 | 1997-07-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR010337A1 true AR010337A1 (es) | 2000-06-07 |
Family
ID=27419527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP970105740A AR010337A1 (es) | 1996-12-05 | 1997-12-05 | Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacuna |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0964699A4 (es) |
| JP (1) | JP2001510992A (es) |
| KR (1) | KR20000069297A (es) |
| CN (1) | CN1246799A (es) |
| AR (1) | AR010337A1 (es) |
| AU (1) | AU739641B2 (es) |
| BR (1) | BR9714133A (es) |
| CA (1) | CA2273199A1 (es) |
| EE (1) | EE9900226A (es) |
| ID (1) | ID21946A (es) |
| IL (1) | IL129746A0 (es) |
| IS (1) | IS5047A (es) |
| NO (1) | NO992158L (es) |
| NZ (1) | NZ335633A (es) |
| PL (1) | PL333943A1 (es) |
| SK (1) | SK57999A3 (es) |
| TR (1) | TR199901262T2 (es) |
| WO (1) | WO1998024475A1 (es) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6188599A (en) * | 1998-10-26 | 2000-05-15 | Novozymes A/S | Constructing and screening a dna library of interest in filamentous fungal cells |
| US7034132B2 (en) | 2001-06-04 | 2006-04-25 | Anderson David W | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| AUPQ347199A0 (en) * | 1999-10-15 | 1999-11-11 | Csl Limited | Novel polypeptide fragments |
| US6951729B1 (en) | 1999-10-27 | 2005-10-04 | Affinium Pharmaceuticals, Inc. | High throughput screening method for biological agents affecting fatty acid biosynthesis |
| US7048926B2 (en) | 2000-10-06 | 2006-05-23 | Affinium Pharmaceuticals, Inc. | Methods of agonizing and antagonizing FabK |
| AU2000277557A1 (en) * | 2000-10-06 | 2002-04-22 | Smith Kline Beecham Corporation | Methods of agonizing and antagonizing fabk |
| WO2002066502A1 (en) * | 2001-02-21 | 2002-08-29 | Boren Thomas | Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
| CN102176907A (zh) * | 2008-10-08 | 2011-09-07 | 免疫解决方案有限公司 | 用于产生粘膜免疫的口服疫苗 |
| JP6959937B2 (ja) * | 2015-12-14 | 2021-11-05 | テクニシェ ユニバーシタット ミュンヘン | ヘリコバクターピロリワクチン |
| CN110343697B (zh) * | 2019-08-05 | 2024-07-12 | 南京昊斯亭网络科技有限公司 | 一种植物病害菌总dna提取方法 |
| CN113435168B (zh) * | 2021-06-10 | 2024-03-22 | 上海美吉生物医药科技有限公司 | 胶图自动编辑方法、系统、终端及介质 |
| CN114057854B (zh) * | 2021-09-30 | 2022-07-15 | 河北医科大学第四医院 | 一种幽门螺杆菌cd4+t细胞耐受多肽融合抗原及其应用 |
| CN116162140A (zh) * | 2022-07-19 | 2023-05-26 | 四川大学华西医院 | 一种幽门螺杆菌重组抗原蛋白SecG及其制备方法与应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9300139L (sv) * | 1993-01-19 | 1994-07-20 | Medicarb Ab | Framställning av ett nytt läkemedel |
-
1997
- 1997-12-05 PL PL97333943A patent/PL333943A1/xx unknown
- 1997-12-05 CA CA002273199A patent/CA2273199A1/en not_active Abandoned
- 1997-12-05 BR BR9714133-0A patent/BR9714133A/pt not_active IP Right Cessation
- 1997-12-05 AU AU58954/98A patent/AU739641B2/en not_active Ceased
- 1997-12-05 IL IL12974697A patent/IL129746A0/xx unknown
- 1997-12-05 JP JP52575898A patent/JP2001510992A/ja active Pending
- 1997-12-05 TR TR1999/01262T patent/TR199901262T2/xx unknown
- 1997-12-05 SK SK579-99A patent/SK57999A3/sk unknown
- 1997-12-05 NZ NZ335633A patent/NZ335633A/xx unknown
- 1997-12-05 ID IDW990495A patent/ID21946A/id unknown
- 1997-12-05 AR ARP970105740A patent/AR010337A1/es not_active Application Discontinuation
- 1997-12-05 WO PCT/US1997/022104 patent/WO1998024475A1/en not_active Application Discontinuation
- 1997-12-05 EP EP97954525A patent/EP0964699A4/en not_active Withdrawn
- 1997-12-05 KR KR1019997004955A patent/KR20000069297A/ko not_active Application Discontinuation
- 1997-12-05 CN CN97181630A patent/CN1246799A/zh active Pending
- 1997-12-05 EE EEP199900226A patent/EE9900226A/xx unknown
-
1999
- 1999-05-04 NO NO992158A patent/NO992158L/no not_active Application Discontinuation
- 1999-05-10 IS IS5047A patent/IS5047A/is unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199901262T2 (xx) | 1999-08-23 |
| AU5895498A (en) | 1998-06-29 |
| CN1246799A (zh) | 2000-03-08 |
| SK57999A3 (en) | 2000-05-16 |
| EE9900226A (et) | 1999-12-15 |
| KR20000069297A (ko) | 2000-11-25 |
| PL333943A1 (en) | 2000-01-31 |
| AU739641B2 (en) | 2001-10-18 |
| NO992158L (no) | 1999-07-05 |
| BR9714133A (pt) | 2000-02-29 |
| CA2273199A1 (en) | 1998-06-11 |
| EP0964699A1 (en) | 1999-12-22 |
| WO1998024475A1 (en) | 1998-06-11 |
| EP0964699A4 (en) | 2005-04-06 |
| IL129746A0 (en) | 2000-02-29 |
| IS5047A (is) | 1999-05-10 |
| NZ335633A (en) | 2000-10-27 |
| ID21946A (id) | 1999-08-12 |
| JP2001510992A (ja) | 2001-08-07 |
| NO992158D0 (no) | 1999-05-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Adermann et al. | Structural and phylogenetic characterization of human SLURP‐1, the first secreted mammalian member of the Ly‐6/uPAR protein superfamily | |
| Denkewalter et al. | Total synthesis of an enzyme. I. Objective and strategy | |
| ES2054878T3 (es) | Expresion de la proapolipoproteina a-i humana. | |
| AR010337A1 (es) | Acido nucleico aislado, molecula de acido nucleico, sonda, vector de expresion recombinante, celula, metodo para producir un polipeptido de h.pylori, metodo para detectar la presencia de un acido nucleico helicobacter, polipeptido de h.pylori aislado, proteina de fusion, formulacion para vacuna | |
| ES2068907T3 (es) | Secuencias de nucleotidos que codifican una proteina con actividad ureasica. | |
| Delbac et al. | On proteins of the microsporidian invasive apparatus: complete sequence of a polar tube protein of Encephalitozoon cuniculi | |
| BR9408006A (pt) | Molécula de ácido nucléico isolada e purificada vetor e vetor de express o adaptados para transformaçao de hospedeiro hospedeiro transformado proteina receptora "transferrin" recombinante ou fragmento ou análogo da mesma proteina Tbpl purificada e isolada proteina Tbp2 purificada e isolada peptídeo composiç o imunogênica vetor ativo para fornecimento de proteina receptora "transferrin" vetor de plasmideo linhagem de haemophilus processo para produzir proteina Tbp2 ou Tbpl purificada e isolada | |
| DE69737413D1 (en) | Bakterioferritin aus helicobacter pylori | |
| Graf et al. | Cathepsin D generates γ-endorphin from β-endorphin | |
| BR9712587A (pt) | cido nucléico, molécula de ácido nucléico, sonda, vetor de expressão recombinante, célula, processos para produzir um polipeptìdeo de h. pylori e para detectar a presença de um ácido nucléico de helicobacter pylori em uma amostra, polipeptìdeo de h. pylori isolado, polipeptìdeos de envelope de célula, celular e secretado de h. pylori ou seus fragmentos, proteìna de fusão, formulação de vacina para a profilaxia ou tratamento de uma infecção por h. pylori, e, processos para tratar ou reduzir um risco de infecção por h. pylori em um sujeito e para produzir uma formulação de vacina. | |
| DE69233245D1 (de) | Verfahren zur Herstellung von Peptiden | |
| ATE357526T1 (de) | Modifizierte hcv peptid-impfstoffe | |
| CA2353802A1 (en) | New protective antigen of group a streptococci | |
| BR9908476A (pt) | Peptìdeo, composição terapêutica, e, processo para conferir imunidade protetora a um paciente, contra a infecção de s. pneumoniae | |
| ATE274059T1 (de) | Transferrinrezeptorgene | |
| DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
| US5573943A (en) | Cloning and expression of a rhoptry associated protein of P. falciparum | |
| NZ512308A (en) | Chlamydia antigens and corresponding DNA fragments and uses thereof | |
| DE68924649D1 (de) | Allelische varianten von -i(plasmodium falciparum) merozoit-oberflächen-antigen. | |
| BR9506666A (pt) | Construçao de DNA vetor de express o replicável processo para a preparaçao de uma bactéria atenuada célula hospedeira composiçao de vacina e processo para o tratamento ou profilaxia de uma infecçao em um mamifero por exemplo um humano | |
| AR010209A1 (es) | Acido nucleico aislado que comprende secuencia que codifica un polipeptido de h.pylori, un vector de expresion recombinante, una celula que comprende esevector, un metodo para la produccion de un polipeptido de h.pylori, una sonda que comprende dicho acido nucleico, una composicion de vacuna para la | |
| AR030293A1 (es) | Una composicion de vacuna que comprende una proteina receptora de fc; un metodo para prepararla; uso de dicha proteina y de un polinucleotido que codifica para dicha proteina y un metodo para tratar o prevenir una infeccion bacteriana | |
| MX9709527A (es) | Genes receptores de transferrina. | |
| HUP0001270A2 (en) | Compositions and methods for the treatment and diagnosis of breast cancer |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |